Treatment of overactive bladder with botulinum toxin type B: a pilot study


The purpose of this study was to determine the efficacy and safety of botulinum toxin type B (BTX-B/Myobloc) in the treatment of patients with overactive bladder. This open-label dose-escalation study enrolled 15 female patients with urinary frequency with or without incontinence. The BTX-B doses used in this study were 2500, 3750, 5000, 10 000 and 15 000… (More)
DOI: 10.1007/s00192-003-1099-3

2 Figures and Tables


  • Presentations referencing similar topics